Mark Allan

Title: Innovations of Mark Allan in Pharmaceutical Composition

Introduction

Mark Allan is an accomplished inventor based in Schwabenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at controlling parasitic infections in animals. His innovative approach combines advanced chemical compounds to enhance the efficacy of medicaments.

Latest Patents

Mark Allan holds a patent for a pharmaceutical composition titled "Suspension comprising benzimidazole carbamate and a polysorbate." This invention is directed to a formulation for drinking water administration that includes benzimidazole carbamate particles with an effective average particle size of less than 450 mm, along with a Tween-type surfactant. The patent outlines a method for creating this composition, its use in developing medicaments for controlling parasites, and its application in protecting animals from parasitic infections. He has 1 patent to his name.

Career Highlights

Mark Allan is associated with Intervet International B.V., a company known for its focus on animal health and veterinary pharmaceuticals. His work at Intervet has allowed him to contribute to advancements in veterinary medicine, particularly in the area of parasitic control.

Collaborations

Throughout his career, Mark has collaborated with notable colleagues, including Carsten Schmidt and Elizabeth Benedicte Daniele Deschamps. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mark Allan's contributions to pharmaceutical compositions demonstrate his commitment to improving animal health through innovative solutions. His patent reflects a significant advancement in the field, showcasing the importance of research and development in veterinary medicine.